| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.724 | 0.003 | 0.852 | Alpha-N-acetylglucosaminidase inhibitor | 0.338 0.013 CID_10005178 0.852 0.002 CID_53831690 | CID_53831690 | |
| 0.671 | 0.011 | 0.671 | Aldehyde oxidase inhibitor | 0.239 0.087 CID_10005178 | ||
| 0.672 | 0.027 | 0.752 | Caspase 9 stimulant | 0.27 0.229 CID_10005178 0.752 0.018 CID_53831690 | CID_53831690 | |
| 0.573 | 0.003 | 0.573 | Alcohol oxidase inhibitor | 0.077 0.025 CID_10005178 0.115 0.015 CID_53831690 | ||
| 0.555 | 0.014 | 0.555 | GABA C receptor rho-3 antagonist | 0.363 0.079 CID_10005178 | ||
| 0.545 | 0.006 | 0.545 | Peroxidase inhibitor | 0.416 0.018 CID_10005178 | ||
| 0.553 | 0.02 | 0.553 | 5 Hydroxytryptamine release stimulant | 0.2 0.121 CID_10005178 0.398 0.046 CID_53831690 | ||
| 0.555 | 0.024 | 0.761 | Cholesterol antagonist | 0.658 0.012 CID_10005178 0.761 0.005 CID_53831690 | CID_53831690 | |
| 0.53 | 0.024 | 0.531 | 5 Hydroxytryptamine release inhibitor | 0.266 0.207 CID_10005178 0.531 0.024 CID_53831690 | CID_53831690 | |
| 0.507 | 0.004 | 0.507 | Tyrosine 3 hydroxylase inhibitor | 0.316 0.026 CID_10005178 0.192 0.151 CID_53831690 | ||
| 0.508 | 0.007 | 0.508 | Anesthetic general | 0.502 0.008 CID_53831690 | ||
| 0.492 | 0.004 | 0.492 | GABA C receptor agonist | 0.173 0.026 CID_10005178 0.128 0.044 CID_53831690 | ||
| 0.527 | 0.043 | 0.89 | Cyclophilin D inhibitor | 0.302 0.161 CID_10005178 0.89 0.005 CID_53831690 | CID_53831690 | |
| 0.49 | 0.032 | 0.579 | Histamine release inhibitor | 0.538 0.019 CID_10005178 0.579 0.012 CID_53831690 | CID_53831690 | |
| 0.494 | 0.036 | 0.494 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.329 0.176 CID_10005178 | ||
| 0.451 | 0.007 | 0.451 | 5 Hydroxytryptamine uptake stimulant | 0.28 0.056 CID_10005178 0.197 0.157 CID_53831690 | ||
| 0.434 | 0.003 | 0.593 | Triose-phosphate isomerase inhibitor | 0.593 0.002 CID_10005178 0.567 0.002 CID_53831690 | CID_10005178 | |
| 0.427 | 0.003 | 0.427 | Ferrochelatase inhibitor | 0.186 0.026 CID_10005178 0.097 0.074 CID_53831690 | ||
| 0.435 | 0.014 | 0.435 | Calcium channel activator | 0.332 0.063 CID_10005178 0.22 0.184 CID_53831690 | ||
| 0.418 | 0.016 | 0.557 | Interleukin agonist | 0.557 0.006 CID_53831690 | CID_53831690 | |
| 0.411 | 0.023 | 0.425 | Hypolipemic | 0.425 0.021 CID_53831690 | CID_53831690 | |
| 0.432 | 0.046 | 0.445 | Vasodilator, peripheral | 0.445 0.042 CID_53831690 | CID_53831690 | |
| 0.389 | 0.029 | 0.733 | Superoxide dismutase inhibitor | 0.733 0.004 CID_10005178 | CID_10005178 | |
| 0.362 | 0.004 | 0.362 | Porphobilinogen synthase inhibitor | 0.22 0.01 CID_10005178 | ||
| 0.355 | 0.002 | 0.355 | Fumarate hydratase inhibitor | 0.052 0.013 CID_10005178 0.122 0.004 CID_53831690 | ||
| 0.377 | 0.025 | 0.511 | DNA synthesis inhibitor | 0.277 0.052 CID_10005178 0.511 0.013 CID_53831690 | CID_53831690 | |
| 0.372 | 0.021 | 0.48 | RNA-directed DNA polymerase inhibitor | 0.48 0.012 CID_10005178 0.32 0.028 CID_53831690 | CID_10005178 | |
| 0.352 | 0.005 | 0.352 | Succinate dehydrogenase inhibitor | 0.266 0.018 CID_10005178 0.183 0.064 CID_53831690 | ||
| 0.354 | 0.01 | 0.354 | Gastrin inhibitor | 0.265 0.062 CID_10005178 0.291 0.04 CID_53831690 | ||
| 0.349 | 0.008 | 0.504 | UDP-glucose 4-epimerase inhibitor | 0.131 0.037 CID_10005178 0.504 0.003 CID_53831690 | CID_53831690 | |
| 0.328 | 0.004 | 0.328 | Carbamoyl phosphate synthetase inhibitor | 0.173 0.009 CID_10005178 0.15 0.011 CID_53831690 | ||
| 0.319 | 0.005 | 0.319 | Glutamate dehydrogenase inhibitor | 0.154 0.015 CID_10005178 0.171 0.013 CID_53831690 | ||
| 0.361 | 0.05 | 0.539 | Vasodilator, coronary | 0.539 0.011 CID_53831690 | CID_53831690 | |
| 0.314 | 0.004 | 0.314 | Argininosuccinate synthase inhibitor | 0.094 0.021 CID_10005178 0.203 0.007 CID_53831690 | ||
| 0.321 | 0.013 | 0.321 | Neurotrophic factor enhancer | 0.276 0.026 CID_53831690 | ||
| 0.324 | 0.017 | 0.468 | Interferon gamma antagonist | 0.137 0.097 CID_10005178 0.468 0.008 CID_53831690 | CID_53831690 | |
| 0.312 | 0.011 | 0.397 | Insulin secretagoues | 0.397 0.006 CID_53831690 | CID_53831690 | |
| 0.298 | 0.007 | 0.298 | Adenylate kinase inhibitor | 0.219 0.013 CID_10005178 0.241 0.011 CID_53831690 | ||
| 0.296 | 0.005 | 0.428 | Phosphofructokinase-1 inhibitor | 0.178 0.014 CID_10005178 0.428 0.003 CID_53831690 | CID_53831690 | |
| 0.294 | 0.005 | 0.294 | GABA C receptor antagonist | 0.278 0.005 CID_10005178 | ||
| 0.293 | 0.004 | 0.293 | Phenylalanine 4-hydroxylase inhibitor | 0.122 0.018 CID_10005178 | ||
| 0.304 | 0.018 | 0.546 | Amylase inhibitor | 0.546 0.005 CID_53831690 | CID_53831690 | |
| 0.282 | 0.007 | 0.356 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.063 CID_10005178 0.356 0.004 CID_53831690 | CID_53831690 | |
| 0.288 | 0.014 | 0.288 | Nitric-oxide synthase stimulant | 0.184 0.119 CID_10005178 0.272 0.02 CID_53831690 | ||
| 0.285 | 0.024 | 0.285 | Lipocortins synthesis antagonist | 0.201 0.055 CID_53831690 | ||
| 0.321 | 0.061 | 0.321 | Sodium/bile acid cotransporter inhibitor | 0.321 0.061 CID_10005178 0.217 0.165 CID_53831690 | ||
| 0.282 | 0.024 | 0.371 | Melanin inhibitor | 0.371 0.014 CID_53831690 | CID_53831690 | |
| 0.264 | 0.007 | 0.565 | NADH dehydrogenase inhibitor | 0.179 0.013 CID_10005178 0.565 0.002 CID_53831690 | CID_53831690 | |
| 0.28 | 0.03 | 0.28 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.238 0.048 CID_53831690 | ||
| 0.265 | 0.016 | 0.292 | Cholesterol synthesis inhibitor | 0.292 0.012 CID_10005178 0.184 0.031 CID_53831690 | CID_10005178 | |
| 0.298 | 0.05 | 0.866 | Angiogenesis stimulant | 0.833 0.003 CID_10005178 0.866 0.003 CID_53831690 | CID_53831690 | |
| 0.317 | 0.074 | 0.555 | Immunostimulant | 0.411 0.046 CID_10005178 0.555 0.022 CID_53831690 | CID_53831690 | |
| 0.336 | 0.094 | 0.561 | Immunosuppressant | 0.29 0.122 CID_10005178 0.561 0.019 CID_53831690 | CID_53831690 | |
| 0.264 | 0.022 | 0.56 | Phospholipase C inhibitor | 0.56 0.005 CID_10005178 0.241 0.027 CID_53831690 | CID_10005178 | |
| 0.246 | 0.006 | 0.246 | Creatine kinase inhibitor | 0.178 0.015 CID_10005178 0.091 0.07 CID_53831690 | ||
| 0.249 | 0.012 | 0.249 | GABA C receptor rho-2 antagonist | 0.136 0.094 CID_10005178 | ||
| 0.315 | 0.079 | 0.673 | Antithrombotic | 0.546 0.023 CID_10005178 0.673 0.01 CID_53831690 | CID_53831690 | |
| 0.245 | 0.009 | 0.245 | Histidine decarboxylase inhibitor | |||
| 0.243 | 0.007 | 0.243 | CF transmembrane conductance regulator agonist | 0.127 0.124 CID_10005178 0.217 0.014 CID_53831690 | ||
| 0.238 | 0.01 | 0.399 | Catalase inhibitor | 0.399 0.004 CID_10005178 0.064 0.061 CID_53831690 | CID_10005178 | |
| 0.244 | 0.017 | 0.403 | Cell wall synthesis inhibitor | 0.403 0.006 CID_10005178 0.394 0.006 CID_53831690 | CID_10005178 | |
| 0.23 | 0.004 | 0.23 | Glycine receptor agonist | 0.131 0.01 CID_10005178 0.204 0.004 CID_53831690 | ||
| 0.232 | 0.006 | 0.232 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.227 | 0.003 | 0.227 | Aconitate hydratase inhibitor | 0.063 0.023 CID_10005178 0.053 0.034 CID_53831690 | ||
| 0.233 | 0.01 | 0.233 | Arachidonic acid antagonist | 0.206 0.028 CID_10005178 0.199 0.034 CID_53831690 | ||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.204 0.055 CID_10005178 | ||
| 0.227 | 0.008 | 0.227 | Antineoplastic alkaloid | |||
| 0.229 | 0.013 | 0.229 | Aurora-C kinase inhibitor | |||
| 0.22 | 0.005 | 0.22 | Biliverdin reductase inhibitor | 0.071 0.032 CID_10005178 0.146 0.01 CID_53831690 | ||
| 0.219 | 0.006 | 0.219 | GABA C receptor rho-1 antagonist | 0.098 0.065 CID_10005178 | ||
| 0.225 | 0.015 | 0.259 | Microtubule formation inhibitor | 0.115 0.066 CID_10005178 0.259 0.006 CID_53831690 | CID_53831690 | |
| 0.286 | 0.076 | 0.381 | Spasmolytic | 0.381 0.044 CID_10005178 0.352 0.052 CID_53831690 | CID_10005178 | |
| 0.239 | 0.029 | 0.39 | Lipid peroxidase inhibitor | 0.13 0.084 CID_10005178 0.39 0.01 CID_53831690 | CID_53831690 | |
| 0.215 | 0.008 | 0.234 | Adenylate cyclase stimulant | 0.234 0.005 CID_10005178 0.184 0.023 CID_53831690 | CID_10005178 | |
| 0.278 | 0.073 | 0.278 | Insulysin inhibitor | |||
| 0.253 | 0.049 | 0.462 | Peptidyltransferase inhibitor | 0.462 0.004 CID_53831690 | CID_53831690 | |
| 0.226 | 0.023 | 0.319 | Hexokinase inhibitor | 0.319 0.009 CID_53831690 | CID_53831690 | |
| 0.297 | 0.096 | 0.72 | Transcription factor NF kappa B inhibitor | 0.291 0.1 CID_10005178 0.72 0.018 CID_53831690 | CID_53831690 | |
| 0.204 | 0.003 | 0.207 | Ca2+-transporting ATPase inhibitor | 0.164 0.018 CID_10005178 0.207 0.003 CID_53831690 | CID_53831690 | |
| 0.205 | 0.005 | 0.205 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 CID_10005178 0.124 0.012 CID_53831690 | ||
| 0.215 | 0.021 | 0.215 | Cystathionine beta-synthase inhibitor | 0.16 0.037 CID_53831690 | ||
| 0.197 | 0.009 | 0.197 | Keratolytic | |||
| 0.232 | 0.046 | 0.232 | Insulin sensitizer | 0.178 0.097 CID_10005178 0.209 0.064 CID_53831690 | ||
| 0.245 | 0.06 | 0.245 | Psychostimulant | 0.195 0.083 CID_53831690 | ||
| 0.189 | 0.008 | 0.189 | Glutamate decarboxylase inhibitor | 0.115 0.022 CID_10005178 | ||
| 0.232 | 0.051 | 0.358 | Non-steroidal antiinflammatory agent | 0.15 0.115 CID_10005178 0.358 0.019 CID_53831690 | CID_53831690 | |
| 0.21 | 0.03 | 0.287 | ATPase inhibitor | 0.287 0.007 CID_53831690 | CID_53831690 | |
| 0.253 | 0.075 | 0.764 | Hypoglycemic | 0.764 0.004 CID_53831690 | CID_53831690 | |
| 0.185 | 0.007 | 0.206 | Interferon agonist | 0.163 0.009 CID_10005178 0.206 0.005 CID_53831690 | CID_53831690 | |
| 0.192 | 0.015 | 0.192 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.204 | 0.028 | 0.245 | Mannose-6-phosphate isomerase inhibitor | 0.245 0.013 CID_53831690 | CID_53831690 | |
| 0.242 | 0.068 | 0.344 | Cyclic AMP phosphodiesterase inhibitor | 0.344 0.027 CID_53831690 | CID_53831690 | |
| 0.179 | 0.005 | 0.179 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.317 | 0.143 | 0.317 | Calcium channel L-type activator | |||
| 0.203 | 0.03 | 0.203 | MAP kinase kinase 5 inhibitor | |||
| 0.194 | 0.023 | 0.284 | Aminopeptidase B inhibitor | 0.284 0.01 CID_10005178 | CID_10005178 | |
| 0.303 | 0.133 | 0.66 | Antibacterial | 0.503 0.04 CID_10005178 0.66 0.012 CID_53831690 | CID_53831690 | |
| 0.181 | 0.011 | 0.181 | Electrolyte absorption antagonist | 0.088 0.077 CID_10005178 | ||
| 0.177 | 0.008 | 0.184 | Anabolic | 0.184 0.006 CID_10005178 0.134 0.028 CID_53831690 | CID_10005178 | |
| 0.243 | 0.075 | 0.243 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.183 | 0.015 | 0.183 | Androgen antagonist | |||
| 0.18 | 0.013 | 0.18 | Prolactin inhibitor | 0.083 0.076 CID_10005178 | ||
| 0.181 | 0.015 | 0.181 | Sphingosine 1-phosphate receptor 2 antagonist | 0.138 0.059 CID_10005178 | ||
| 0.173 | 0.008 | 0.205 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 CID_10005178 0.205 0.006 CID_53831690 | CID_53831690 | |
| 0.235 | 0.071 | 0.235 | Neuropeptide Y2 antagonist | |||
| 0.173 | 0.009 | 0.173 | Cyclin B3 inhibitor | |||
| 0.181 | 0.018 | 0.2 | Mucolytic | 0.126 0.049 CID_10005178 0.2 0.013 CID_53831690 | CID_53831690 | |
| 0.175 | 0.012 | 0.175 | DOPA decarboxylase inhibitor | 0.1 0.077 CID_10005178 | ||
| 0.203 | 0.04 | 0.292 | Protein kinase stimulant | 0.292 0.018 CID_53831690 | CID_53831690 | |
| 0.18 | 0.018 | 0.18 | Pregnane X receptor agonist | 0.167 0.029 CID_10005178 | ||
| 0.165 | 0.005 | 0.217 | Glycine receptor antagonist | 0.217 0.003 CID_10005178 0.199 0.004 CID_53831690 | CID_10005178 | |
| 0.177 | 0.019 | 0.177 | Vanilloid 1 agonist | 0.147 0.042 CID_10005178 0.162 0.028 CID_53831690 | ||
| 0.175 | 0.019 | 0.244 | Photosensitizer | 0.129 0.047 CID_10005178 0.244 0.006 CID_53831690 | CID_53831690 | |
| 0.173 | 0.018 | 0.173 | HIV-1 integrase (Overall Integration) inhibitor | 0.135 0.031 CID_10005178 | ||
| 0.154 | 0.004 | 0.154 | Glutamate (mGluR6) antagonist | 0.079 0.025 CID_10005178 0.088 0.017 CID_53831690 | ||
| 0.18 | 0.029 | 0.18 | Farnesoid X receptor antagonist | |||
| 0.157 | 0.007 | 0.314 | GABA aminotransferase inhibitor | 0.314 0.003 CID_53831690 | CID_53831690 | |
| 0.163 | 0.015 | 0.163 | Electron transport complex I inhibitor | |||
| 0.176 | 0.03 | 0.362 | Cyclooxygenase 3 inhibitor | 0.362 0.004 CID_53831690 | CID_53831690 | |
| 0.156 | 0.012 | 0.156 | Aminopeptidase I inhibitor | 0.079 0.043 CID_10005178 | ||
| 0.205 | 0.062 | 0.622 | Hepatoprotectant | 0.221 0.054 CID_10005178 0.622 0.004 CID_53831690 | CID_53831690 | |
| 0.146 | 0.003 | 0.191 | Glucose-6-phosphate isomerase inhibitor | 0.091 0.006 CID_10005178 0.191 0.002 CID_53831690 | CID_53831690 | |
| 0.165 | 0.022 | 0.165 | TRPA1 agonist | 0.15 0.031 CID_10005178 | ||
| 0.177 | 0.035 | 0.177 | Aldehyde dehydrogenase inhibitor | 0.155 0.044 CID_53831690 | ||
| 0.206 | 0.065 | 0.591 | Nitric oxide antagonist | 0.591 0.01 CID_53831690 | CID_53831690 | |
| 0.155 | 0.016 | 0.155 | ABCA1 expression enhancer | |||
| 0.144 | 0.005 | 0.144 | Mineralocorticoid receptor antagonist | |||
| 0.184 | 0.046 | 0.184 | Neurotensin receptor agonist | |||
| 0.142 | 0.005 | 0.142 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.091 0.012 CID_10005178 | ||
| 0.141 | 0.005 | 0.141 | GABA B receptor agonist | 0.088 0.029 CID_10005178 | ||
| 0.14 | 0.005 | 0.14 | Liver X receptor agonist | |||
| 0.165 | 0.03 | 0.165 | Falcipain 3 inhibitor | |||
| 0.233 | 0.099 | 0.233 | Transcription factor STAT3 inhibitor | |||
| 0.138 | 0.005 | 0.149 | Interferon inducer | 0.131 0.006 CID_10005178 0.149 0.005 CID_53831690 | CID_53831690 | |
| 0.158 | 0.026 | 0.158 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.162 | 0.031 | 0.398 | Expectorant | 0.096 0.073 CID_10005178 0.398 0.005 CID_53831690 | CID_53831690 | |
| 0.152 | 0.021 | 0.152 | Folate antagonist | 0.092 0.082 CID_53831690 | ||
| 0.207 | 0.078 | 0.207 | MAP kinase kinase 2 inhibitor | |||
| 0.142 | 0.014 | 0.142 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.156 | 0.028 | 0.156 | Carbonic anhydrase XV inhibitor | 0.144 0.033 CID_10005178 | ||
| 0.158 | 0.031 | 0.158 | Heat shock protein 70 antagonist | 0.156 0.033 CID_53831690 | ||
| 0.135 | 0.009 | 0.135 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.071 CID_10005178 | ||
| 0.133 | 0.009 | 0.133 | Purinergic P2X1 antagonist | 0.099 0.017 CID_10005178 0.092 0.019 CID_53831690 | ||
| 0.184 | 0.062 | 0.184 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.163 | 0.041 | 0.163 | Nav1.6 sodium channel blocker | |||
| 0.129 | 0.009 | 0.129 | Androgen agonist | 0.107 0.012 CID_10005178 | ||
| 0.162 | 0.044 | 0.162 | Toll-Like receptor 2 antagonist | |||
| 0.219 | 0.102 | 0.763 | Antioxidant | 0.29 0.065 CID_10005178 0.763 0.005 CID_53831690 | CID_53831690 | |
| 0.15 | 0.034 | 0.15 | Interleukin 8 antagonist | |||
| 0.153 | 0.038 | 0.22 | Beta amyloid protein antagonist | 0.137 0.051 CID_10005178 0.22 0.012 CID_53831690 | CID_53831690 | |
| 0.131 | 0.016 | 0.166 | Glutamate release inhibitor | 0.166 0.007 CID_53831690 | CID_53831690 | |
| 0.192 | 0.078 | 0.192 | I kappa B kinase epsilon inhibitor | |||
| 0.138 | 0.025 | 0.138 | Factor V inhibitor | |||
| 0.141 | 0.029 | 0.141 | Sphingomyelinase inhibitor | 0.125 0.038 CID_53831690 | ||
| 0.124 | 0.012 | 0.124 | Ornithine carbamoyltransferase inhibitor | 0.076 0.023 CID_10005178 0.075 0.023 CID_53831690 | ||
| 0.154 | 0.043 | 0.154 | Cathepsin H inhibitor | 0.122 0.073 CID_10005178 | ||
| 0.12 | 0.01 | 0.12 | Estrogen-related receptor beta agonist | 0.078 0.075 CID_10005178 | ||
| 0.113 | 0.005 | 0.306 | Alpha-mannosidase inhibitor | 0.281 0.002 CID_10005178 0.306 0.002 CID_53831690 | CID_53831690 | |
| 0.132 | 0.026 | 0.132 | Potassium channel activator | |||
| 0.238 | 0.133 | 0.571 | Interleukin 2 agonist | 0.571 0.004 CID_53831690 | CID_53831690 | |
| 0.13 | 0.026 | 0.239 | Carbonic anhydrase XIII inhibitor | 0.239 0.009 CID_10005178 0.11 0.034 CID_53831690 | CID_10005178 | |
| 0.137 | 0.034 | 0.17 | Carbonic anhydrase III inhibitor | 0.17 0.022 CID_10005178 0.105 0.057 CID_53831690 | CID_10005178 | |
| 0.106 | 0.003 | 0.106 | Parathyroid hormone antagonist | |||
| 0.156 | 0.054 | 0.156 | Bone formation stimulant | |||
| 0.148 | 0.048 | 0.327 | Monophenol monooxygenase inhibitor | 0.172 0.04 CID_10005178 0.327 0.015 CID_53831690 | CID_53831690 | |
| 0.124 | 0.023 | 0.124 | Ornithine decarboxylase inhibitor | 0.092 0.053 CID_53831690 | ||
| 0.129 | 0.029 | 0.129 | Alcohol dehydrogenase inhibitor | 0.118 0.036 CID_53831690 | ||
| 0.114 | 0.015 | 0.237 | NMDA receptor agonist | 0.237 0.004 CID_10005178 | CID_10005178 | |
| 0.126 | 0.029 | 0.126 | MAP kinase kinase 1 inhibitor | |||
| 0.128 | 0.031 | 0.128 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.121 | 0.024 | 0.189 | Phosphodiesterase 6D inhibitor | 0.136 0.014 CID_10005178 0.189 0.005 CID_53831690 | CID_53831690 | |
| 0.109 | 0.012 | 0.109 | NMDA receptor glycine site agonist | 0.054 0.052 CID_10005178 | ||
| 0.215 | 0.118 | 0.215 | Transcription factor STAT inhibitor | |||
| 0.161 | 0.065 | 0.2 | Phospholipase A2 inhibitor | 0.2 0.043 CID_10005178 0.18 0.054 CID_53831690 | CID_10005178 | |
| 0.113 | 0.017 | 0.113 | D-Ala-D-Ala ligase inhibitor | |||
| 0.106 | 0.01 | 0.106 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.115 | 0.02 | 0.137 | Na+ K+ transporting ATPase inhibitor | 0.137 0.009 CID_10005178 0.136 0.009 CID_53831690 | CID_10005178 | |
| 0.101 | 0.006 | 0.101 | MDM2 inhibitor | |||
| 0.127 | 0.032 | 0.127 | Calcium antagonist | |||
| 0.134 | 0.039 | 0.353 | AMP-activated protein kinase stimulant | 0.353 0.004 CID_53831690 | CID_53831690 | |
| 0.104 | 0.01 | 0.104 | MAP kinase kinase 7 inhibitor | |||
| 0.107 | 0.012 | 0.107 | Vanilloid 4 agonist | 0.074 0.054 CID_10005178 | ||
| 0.107 | 0.013 | 0.107 | Potassium channel (ATP-sensitive) blocker | |||
| 0.143 | 0.05 | 0.143 | Adenylate cyclase inhibitor | 0.119 0.068 CID_53831690 | ||
| 0.098 | 0.006 | 0.285 | Mannosidase inhibitor | 0.244 0.003 CID_10005178 0.285 0.002 CID_53831690 | CID_53831690 | |
| 0.101 | 0.009 | 0.101 | Exportin-1 inhibitor | 0.065 0.056 CID_10005178 | ||
| 0.12 | 0.03 | 0.12 | Glutamate (mGluR7) agonist | |||
| 0.13 | 0.041 | 0.13 | Protease inhibitor | |||
| 0.141 | 0.052 | 0.141 | Proteasome inhibitor | |||
| 0.202 | 0.113 | 0.272 | DNA damaging | 0.272 0.069 CID_53831690 | CID_53831690 | |
| 0.14 | 0.052 | 0.299 | Alkylator | 0.172 0.036 CID_10005178 0.299 0.013 CID_53831690 | CID_53831690 | |
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | |||
| 0.089 | 0.004 | 0.118 | Cytokine production stimulant | 0.118 0.004 CID_53831690 | CID_53831690 | |
| 0.108 | 0.025 | 0.108 | mTOR complex 2 inhibitor | |||
| 0.088 | 0.005 | 0.088 | Adenylate cyclase 1 inhibitor | |||
| 0.098 | 0.016 | 0.145 | Phospholipase D inhibitor | 0.145 0.004 CID_10005178 | CID_10005178 | |
| 0.097 | 0.016 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.032 CID_10005178 | ||
| 0.086 | 0.005 | 0.086 | Pregnane X receptor antagonist | 0.055 0.045 CID_10005178 | ||
| 0.089 | 0.009 | 0.089 | Calcium channel P-type blocker | |||
| 0.12 | 0.043 | 0.153 | Gastric antisecretory | 0.153 0.025 CID_10005178 | CID_10005178 | |
| 0.1 | 0.022 | 0.1 | CC chemokine 5 receptor agonist | 0.099 0.023 CID_10005178 | ||
| 0.134 | 0.057 | 0.134 | Anesthetic local | |||
| 0.082 | 0.005 | 0.082 | Membrane dipeptidase inhibitor | 0.043 0.022 CID_10005178 | ||
| 0.084 | 0.008 | 0.084 | Glutamate (mGluR1a) antagonist | |||
| 0.094 | 0.019 | 0.094 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.076 0.027 CID_53831690 | ||
| 0.079 | 0.004 | 0.079 | Kainate receptor agonist | 0.041 0.028 CID_10005178 0.044 0.023 CID_53831690 | ||
| 0.084 | 0.009 | 0.084 | Squalene epoxidase inhibitor | 0.072 0.013 CID_53831690 | ||
| 0.087 | 0.012 | 0.087 | Topoisomerase II beta inhibitor | 0.05 0.033 CID_53831690 | ||
| 0.082 | 0.007 | 0.082 | Potassium channel (Inward rectifier) activator | 0.064 0.016 CID_10005178 | ||
| 0.083 | 0.009 | 0.083 | Dihydroorotate oxidase inhibitor | 0.055 0.037 CID_10005178 | ||
| 0.121 | 0.047 | 0.171 | Acetylcholine release stimulant | 0.171 0.008 CID_10005178 0.136 0.027 CID_53831690 | CID_10005178 | |
| 0.081 | 0.008 | 0.12 | Phosphoglycerate kinase inhibitor | 0.12 0.006 CID_10005178 0.036 0.023 CID_53831690 | CID_10005178 | |
| 0.085 | 0.013 | 0.085 | Sphingosine kinase inhibitor | 0.078 0.017 CID_10005178 | ||
| 0.079 | 0.007 | 0.079 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 CID_10005178 | ||
| 0.076 | 0.004 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 CID_10005178 | ||
| 0.083 | 0.012 | 0.083 | Potassium channel (Inward rectifier) blocker | |||
| 0.077 | 0.007 | 0.077 | Dopamine D5 agonist | |||
| 0.076 | 0.005 | 0.076 | GABA uptake inhibitor | |||
| 0.083 | 0.014 | 0.083 | Sphingosine kinase 2 inhibitor | |||
| 0.075 | 0.006 | 0.075 | Geranyltranstransferase inhibitor | |||
| 0.09 | 0.021 | 0.097 | Protease 3C (Human rhinovirus) inhibitor | 0.097 0.017 CID_10005178 | CID_10005178 | |
| 0.075 | 0.006 | 0.097 | Arginase inhibitor | 0.097 0.004 CID_53831690 | CID_53831690 | |
| 0.122 | 0.054 | 0.122 | 5 Hydroxytryptamine 3A agonist | |||
| 0.102 | 0.035 | 0.102 | Glutathione S-transferase inhibitor | |||
| 0.069 | 0.002 | 0.069 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.143 | 0.076 | 0.379 | Hemostatic | 0.376 0.009 CID_10005178 0.379 0.009 CID_53831690 | CID_53831690 | |
| 0.123 | 0.056 | 0.123 | Caspase 3 inhibitor | |||
| 0.134 | 0.068 | 0.134 | NADPH oxidase inhibitor | |||
| 0.072 | 0.007 | 0.072 | Liver X receptor beta agonist | |||
| 0.07 | 0.005 | 0.07 | Glutamate (mGluR8) agonist | 0.035 0.033 CID_10005178 | ||
| 0.087 | 0.021 | 0.172 | Neuraminidase (influenza) inhibitor | 0.172 0.005 CID_10005178 0.168 0.006 CID_53831690 | CID_10005178 | |
| 0.081 | 0.016 | 0.081 | Transcription factor RelA inhibitor | |||
| 0.087 | 0.023 | 0.087 | Carbonic anhydrase stimulant | |||
| 0.157 | 0.092 | 0.157 | Tumour necrosis factor antagonist | |||
| 0.072 | 0.008 | 0.072 | Glucocorticoid antagonist | |||
| 0.142 | 0.078 | 0.142 | Thiol protease inhibitor | |||
| 0.13 | 0.067 | 0.178 | Antibacterial (Helicobacter pylori) | 0.178 0.029 CID_10005178 | CID_10005178 | |
| 0.072 | 0.008 | 0.072 | Liver X receptor alpha agonist | |||
| 0.068 | 0.005 | 0.077 | Guanylate cyclase inhibitor | 0.077 0.003 CID_10005178 0.069 0.005 CID_53831690 | CID_10005178 | |
| 0.113 | 0.051 | 0.193 | Xanthine oxidase inhibitor | 0.193 0.021 CID_53831690 | CID_53831690 | |
| 0.091 | 0.03 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.104 | 0.042 | 0.141 | Bile acid receptor antagonist | 0.141 0.009 CID_10005178 | CID_10005178 | |
| 0.074 | 0.013 | 0.074 | Ryanodine receptor antagonist | |||
| 0.073 | 0.012 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.052 0.033 CID_10005178 | ||
| 0.065 | 0.005 | 0.065 | ATP citrate lysase inhibitor | |||
| 0.07 | 0.01 | 0.07 | Retinoid X receptor agonist | |||
| 0.186 | 0.127 | 0.186 | Calpain inhibitor | |||
| 0.073 | 0.013 | 0.073 | Aldosterone antagonist | |||
| 0.072 | 0.013 | 0.074 | Adenosine deaminase inhibitor | 0.074 0.011 CID_10005178 0.068 0.014 CID_53831690 | CID_10005178 | |
| 0.098 | 0.039 | 0.098 | Glutamate receptor agonist | 0.072 0.061 CID_10005178 | ||
| 0.232 | 0.174 | 0.265 | Antiobesity | 0.265 0.144 CID_53831690 | CID_53831690 | |
| 0.099 | 0.041 | 0.099 | Bromodomain-containing protein 2 inhibitor | |||
| 0.073 | 0.016 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.072 | 0.015 | 0.104 | Glutamate (mGluR group I) agonist | 0.104 0.008 CID_10005178 | CID_10005178 | |
| 0.075 | 0.019 | 0.09 | Glucosylceramidase inhibitor | 0.09 0.011 CID_53831690 | CID_53831690 | |
| 0.083 | 0.027 | 0.083 | Potassium channel (Tandem pore domain) blocker | |||
| 0.088 | 0.032 | 0.113 | HIV-1 integrase inhibitor | 0.113 0.018 CID_10005178 | CID_10005178 | |
| 0.06 | 0.004 | 0.06 | Vitamin D receptor antagonist | 0.024 0.011 CID_53831690 | ||
| 0.066 | 0.011 | 0.066 | AICAR transformylase inhibitor | 0.06 0.014 CID_10005178 | ||
| 0.169 | 0.115 | 0.169 | Histone acetyltransferase inhibitor | |||
| 0.1 | 0.046 | 0.1 | Histamine N-methyltransferase inhibitor | |||
| 0.139 | 0.086 | 0.139 | MAP kinase 3 inhibitor | |||
| 0.16 | 0.107 | 0.16 | Pyruvate kinase inhibitor | |||
| 0.118 | 0.064 | 0.118 | Transcription factor STAT6 inhibitor | |||
| 0.063 | 0.01 | 0.077 | Neuraminidase (Influenza A) inhibitor | 0.077 0.005 CID_53831690 | CID_53831690 | |
| 0.082 | 0.031 | 0.082 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.079 | 0.028 | 0.079 | Aryl hydrocarbon receptor antagonist | |||
| 0.066 | 0.015 | 0.066 | Immunoglobulin Fc receptor antagonist | |||
| 0.083 | 0.033 | 0.083 | Secretase beta inhibitor | |||
| 0.108 | 0.058 | 0.108 | Urease inhibitor | |||
| 0.061 | 0.011 | 0.061 | Retinoid X alpha receptor agonist | |||
| 0.14 | 0.09 | 0.14 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.053 | 0.004 | 0.053 | Glucocorticoid agonist | |||
| 0.077 | 0.028 | 0.133 | Neuraminidase inhibitor | 0.106 0.013 CID_10005178 0.133 0.008 CID_53831690 | CID_53831690 | |
| 0.091 | 0.043 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.064 | 0.016 | 0.102 | Glutamate (mGluR5) agonist | 0.102 0.007 CID_10005178 | CID_10005178 | |
| 0.146 | 0.098 | 0.146 | Antipruritic | |||
| 0.092 | 0.044 | 0.12 | Carbonic anhydrase VI inhibitor | 0.12 0.029 CID_10005178 | CID_10005178 | |
| 0.12 | 0.073 | 0.205 | DNA repair enzyme inhibitor | 0.205 0.008 CID_53831690 | CID_53831690 | |
| 0.057 | 0.011 | 0.057 | Sphingosine kinase 1 inhibitor | |||
| 0.061 | 0.017 | 0.061 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.133 | 0.088 | 0.133 | Cytidine deaminase inhibitor | |||
| 0.056 | 0.012 | 0.056 | Nerve growth factor antagonist | |||
| 0.057 | 0.012 | 0.057 | Alpha 1d adrenoreceptor agonist | |||
| 0.099 | 0.055 | 0.099 | Potassium channel (Voltage-sensitive) activator | |||
| 0.058 | 0.014 | 0.058 | Thymidine kinase inhibitor | 0.051 0.018 CID_10005178 0.041 0.029 CID_53831690 | ||
| 0.06 | 0.016 | 0.06 | CC chemokine 4 receptor antagonist | |||
| 0.085 | 0.041 | 0.085 | Estrogen receptor alpha antagonist | |||
| 0.063 | 0.019 | 0.063 | CD45 antagonist | |||
| 0.051 | 0.008 | 0.051 | Liver X receptor beta antagonist | |||
| 0.067 | 0.024 | 0.084 | Lipocortins synthesis agonist | 0.058 0.041 CID_10005178 0.084 0.011 CID_53831690 | CID_53831690 | |
| 0.134 | 0.091 | 0.345 | Diuretic | 0.345 0.017 CID_10005178 0.208 0.041 CID_53831690 | CID_10005178 | |
| 0.053 | 0.01 | 0.053 | Retinoid X receptor antagonist | |||
| 0.05 | 0.008 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 CID_53831690 | CID_53831690 | |
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.058 | 0.016 | 0.058 | CDK5/p25 inhibitor | |||
| 0.046 | 0.004 | 0.046 | Nicotinic acid receptor 2 antagonist | |||
| 0.054 | 0.012 | 0.054 | p53 inhibitor | |||
| 0.063 | 0.022 | 0.063 | Leukotriene C antagonist | |||
| 0.048 | 0.008 | 0.048 | Cholesterol ester transfer protein antagonist | 0.037 0.015 CID_10005178 | ||
| 0.058 | 0.017 | 0.066 | Microtubule stabilization | 0.066 0.009 CID_53831690 | CID_53831690 | |
| 0.045 | 0.005 | 0.045 | Prostaglandin F2 alpha agonist | 0.021 0.018 CID_53831690 | ||
| 0.068 | 0.028 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.046 | 0.006 | 0.046 | Glutamate (mGluR3) agonist | 0.03 0.028 CID_53831690 | ||
| 0.132 | 0.093 | 0.132 | Acetylcholine M1 receptor antagonist | |||
| 0.06 | 0.021 | 0.06 | HCV NS3/NS4A protease inhibitor | |||
| 0.085 | 0.046 | 0.085 | Macrophage migration inhibitory factor inhibitor | |||
| 0.147 | 0.107 | 0.246 | DNA methyltransferase I inhibitor | 0.246 0.049 CID_53831690 | CID_53831690 | |
| 0.055 | 0.016 | 0.055 | Glutamate (mGluR group III) antagonist | |||
| 0.066 | 0.026 | 0.066 | Phosphodiesterase II inhibitor | |||
| 0.044 | 0.005 | 0.044 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_53831690 | ||
| 0.052 | 0.013 | 0.08 | Farnesoid X receptor agonist | 0.08 0.005 CID_10005178 | CID_10005178 | |
| 0.079 | 0.04 | 0.079 | Prostaglandin-E synthase inhibitor | |||
| 0.107 | 0.069 | 0.107 | GABA receptor agonist | |||
| 0.048 | 0.01 | 0.048 | Vanilloid 3 antagonist | |||
| 0.081 | 0.043 | 0.159 | Cathepsin G inhibitor | 0.159 0.02 CID_10005178 | CID_10005178 | |
| 0.105 | 0.068 | 0.105 | Protein kinase C gamma inhibitor | |||
| 0.046 | 0.009 | 0.046 | Retinoid X alpha receptor antagonist | |||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | |||
| 0.046 | 0.01 | 0.046 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.025 CID_10005178 | ||
| 0.049 | 0.013 | 0.049 | Glutamate (mGluR3) antagonist | |||
| 0.044 | 0.008 | 0.044 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | |||
| 0.083 | 0.046 | 0.083 | CYP2A6 inhibitor | |||
| 0.046 | 0.011 | 0.046 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.04 | 0.005 | 0.04 | Estrogen-related receptor gamma antagonist | |||
| 0.039 | 0.004 | 0.053 | Vanilloid 2 agonist | 0.038 0.005 CID_10005178 0.053 0.003 CID_53831690 | CID_53831690 | |
| 0.06 | 0.026 | 0.06 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.065 | 0.031 | 0.065 | Beta 2 adrenoreceptor agonist | 0.061 0.045 CID_10005178 | ||
| 0.048 | 0.014 | 0.048 | Potassium channel Kv1.1 blocker | |||
| 0.037 | 0.004 | 0.037 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 CID_53831690 | ||
| 0.048 | 0.015 | 0.069 | Squalene synthetase inhibitor | 0.032 0.023 CID_10005178 0.069 0.01 CID_53831690 | CID_53831690 | |
| 0.039 | 0.006 | 0.039 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.058 | 0.025 | 0.058 | Phosphodiesterase 2A inhibitor | |||
| 0.038 | 0.006 | 0.192 | Glutamate (mGluR1a) agonist | 0.192 0.002 CID_10005178 | CID_10005178 | |
| 0.046 | 0.014 | 0.046 | Integrin alpha2 antagonist | |||
| 0.058 | 0.027 | 0.058 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.05 | 0.018 | 0.05 | Angiotensin AT1 receptor antagonist | |||
| 0.053 | 0.022 | 0.053 | Oxytocin agonist | |||
| 0.053 | 0.022 | 0.053 | Dihydroorotase inhibitor | |||
| 0.192 | 0.161 | 0.211 | Hypoxia-inducible factor 1 alpha inhibitor | 0.193 0.161 CID_10005178 0.211 0.14 CID_53831690 | CID_53831690 | |
| 0.039 | 0.009 | 0.039 | Prostaglandin EP2 agonist | |||
| 0.042 | 0.011 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 CID_53831690 | ||
| 0.149 | 0.118 | 0.295 | DNA methylase inhibitor | 0.295 0.029 CID_53831690 | CID_53831690 | |
| 0.063 | 0.033 | 0.19 | Carbonic anhydrase VB inhibitor | 0.19 0.005 CID_10005178 | CID_10005178 | |
| 0.063 | 0.033 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.033 | 0.003 | 0.045 | Telomerase stimulant | 0.018 0.01 CID_10005178 0.045 0.002 CID_53831690 | CID_53831690 | |
| 0.072 | 0.042 | 0.072 | Acetylcholine M5 receptor agonist | |||
| 0.043 | 0.012 | 0.043 | Prostaglandin agonist | |||
| 0.036 | 0.006 | 0.185 | Glutamate (mGluR1) agonist | 0.185 0.003 CID_10005178 | CID_10005178 | |
| 0.048 | 0.019 | 0.048 | Progesterone antagonist | |||
| 0.05 | 0.021 | 0.05 | HIV-1 protease inhibitor | |||
| 0.086 | 0.056 | 0.086 | Myeloperoxidase inhibitor | |||
| 0.049 | 0.02 | 0.049 | GABA B receptor antagonist | |||
| 0.047 | 0.018 | 0.047 | AMPA 4 receptor antagonist | |||
| 0.033 | 0.004 | 0.033 | Carbonic anhydrase X inhibitor | 0.016 0.012 CID_10005178 | ||
| 0.033 | 0.004 | 0.033 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 CID_10005178 | ||
| 0.04 | 0.011 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 CID_53831690 | ||
| 0.049 | 0.021 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.037 | 0.009 | 0.113 | Sodium/glucose cotransporter 2 inhibitor | 0.113 0.002 CID_53831690 | CID_53831690 | |
| 0.045 | 0.017 | 0.045 | Nicotinic acid receptor agonist | |||
| 0.042 | 0.014 | 0.042 | Free fatty acid receptor 1 antagonist | |||
| 0.045 | 0.018 | 0.045 | MAP3K5 inhibitor | |||
| 0.074 | 0.047 | 0.074 | Calcium channel L-type blocker | |||
| 0.04 | 0.013 | 0.04 | Prostaglandin D2 agonist | |||
| 0.083 | 0.057 | 0.114 | Inducible nitric-oxide synthase inhibitor | 0.114 0.028 CID_10005178 | CID_10005178 | |
| 0.058 | 0.031 | 0.085 | Leukotriene B4 antagonist | 0.05 0.044 CID_10005178 0.085 0.014 CID_53831690 | CID_53831690 | |
| 0.085 | 0.058 | 0.085 | Vanilloid agonist | |||
| 0.091 | 0.064 | 0.091 | Potassium channel (Ca-activated) activator | |||
| 0.053 | 0.026 | 0.053 | Cholesterol esterase inhibitor | 0.044 0.039 CID_53831690 | ||
| 0.066 | 0.04 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.04 | 0.014 | 0.04 | Peptide deformylase inhibitor | |||
| 0.18 | 0.154 | 0.18 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.053 | 0.027 | 0.053 | Potassium channel Kv1.3 blocker | |||
| 0.189 | 0.163 | 0.189 | 12-Lipoxygenase inhibitor | |||
| 0.068 | 0.042 | 0.069 | Leukotriene antagonist | 0.069 0.04 CID_53831690 | CID_53831690 | |
| 0.046 | 0.02 | 0.046 | G protein-coupled receptor agonist | |||
| 0.03 | 0.004 | 0.03 | Retinoid X beta receptor antagonist | |||
| 0.035 | 0.01 | 0.035 | LFA antagonist | |||
| 0.062 | 0.037 | 0.062 | Cyclin H inhibitor | |||
| 0.078 | 0.053 | 0.078 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.034 | 0.009 | 0.034 | Integrin alpha2beta1 antagonist | |||
| 0.077 | 0.052 | 0.077 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.033 | 0.009 | 0.135 | Sodium/glucose cotransporter inhibitor | 0.135 0.002 CID_53831690 | CID_53831690 | |
| 0.057 | 0.033 | 0.057 | Epithelial sodium channel blocker | |||
| 0.048 | 0.025 | 0.199 | Leukocyte elastase inhibitor | 0.199 0.004 CID_10005178 | CID_10005178 | |
| 0.092 | 0.068 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.028 | 0.005 | 0.028 | Toll-Like receptor 8 agonist | |||
| 0.027 | 0.004 | 0.027 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.042 | 0.019 | 0.042 | CF transmembrane conductance regulator antagonist | |||
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CID_10005178 0.025 0.024 CID_53831690 | ||
| 0.052 | 0.03 | 0.054 | Factor III inhibitor | 0.054 0.025 CID_53831690 | CID_53831690 | |
| 0.039 | 0.017 | 0.039 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.038 | 0.015 | 0.038 | Liver X receptor antagonist | |||
| 0.037 | 0.015 | 0.037 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.039 | 0.017 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.047 | 0.025 | 0.064 | Toll-Like receptor 2 agonist | 0.064 0.019 CID_53831690 | CID_53831690 | |
| 0.026 | 0.005 | 0.053 | Antibiotic Anthracycline-like | 0.018 0.017 CID_10005178 0.053 0.001 CID_53831690 | CID_53831690 | |
| 0.037 | 0.015 | 0.037 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.056 | 0.034 | 0.18 | Protein 50S ribosomal subunit inhibitor | 0.18 0.005 CID_53831690 | CID_53831690 | |
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | |||
| 0.056 | 0.035 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.06 | 0.039 | 0.06 | Heat shock protein 90 beta antagonist | |||
| 0.029 | 0.008 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.074 | 0.053 | 0.09 | Phosphodiesterase VI inhibitor | 0.069 0.065 CID_10005178 0.09 0.028 CID_53831690 | CID_53831690 | |
| 0.125 | 0.105 | 0.379 | Thrombolytic | 0.352 0.016 CID_10005178 0.379 0.013 CID_53831690 | CID_53831690 | |
| 0.055 | 0.035 | 0.055 | Lysine-specific demethylase 1A inhibitor | |||
| 0.129 | 0.109 | 0.129 | Growth hormone agonist | |||
| 0.093 | 0.073 | 0.101 | Nitric-oxide synthase inhibitor | 0.101 0.059 CID_10005178 | CID_10005178 | |
| 0.056 | 0.037 | 0.056 | Cyclin B2 inhibitor | |||
| 0.024 | 0.004 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.01 CID_53831690 | ||
| 0.035 | 0.016 | 0.035 | Epoxide hydrolase 1 inhibitor | |||
| 0.065 | 0.046 | 0.065 | Beta adrenoreceptor antagonist | |||
| 0.037 | 0.018 | 0.043 | HMG CoA reductase inhibitor | 0.043 0.012 CID_53831690 | CID_53831690 | |
| 0.024 | 0.005 | 0.024 | Vitamin D receptor agonist | 0.021 0.006 CID_53831690 | ||
| 0.04 | 0.022 | 0.04 | Kainate receptor 2 antagonist | |||
| 0.027 | 0.008 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 CID_53831690 | ||
| 0.024 | 0.006 | 0.024 | Nicotinic acid receptor 1 antagonist | |||
| 0.069 | 0.05 | 0.069 | Protein kinase C beta inhibitor | |||
| 0.048 | 0.03 | 0.048 | Thymidylate synthase inhibitor | |||
| 0.032 | 0.014 | 0.032 | Lysine carboxypeptidase inhibitor | |||
| 0.051 | 0.034 | 0.051 | Beta 2 adrenoreceptor antagonist | |||
| 0.042 | 0.025 | 0.042 | Dihydropteroate synthase inhibitor | |||
| 0.058 | 0.041 | 0.058 | Glutamate (mGluR1) antagonist | |||
| 0.038 | 0.021 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.049 0.007 CID_10005178 0.04 0.017 CID_53831690 | CID_10005178 | |
| 0.036 | 0.02 | 0.036 | Angiotensin II receptor antagonist | |||
| 0.113 | 0.096 | 0.185 | Interleukin 4 antagonist | 0.185 0.027 CID_53831690 | CID_53831690 | |
| 0.03 | 0.013 | 0.03 | Calcium-sensing receptor agonist | |||
| 0.033 | 0.016 | 0.033 | Elastase 3A inhibitor | |||
| 0.033 | 0.016 | 0.033 | Elastase 3B inhibitor | |||
| 0.033 | 0.016 | 0.033 | Elastase 2B inhibitor | |||
| 0.059 | 0.042 | 0.059 | Collagenase 3 inhibitor | |||
| 0.054 | 0.038 | 0.054 | Thromboxane synthase inhibitor | |||
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.056 | 0.04 | 0.056 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.089 | 0.105 | MAP kinase kinase inhibitor | |||
| 0.058 | 0.043 | 0.058 | Cathepsin E inhibitor | |||
| 0.038 | 0.023 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.032 | 0.016 | 0.032 | Liver X receptor alpha antagonist | |||
| 0.043 | 0.028 | 0.043 | Heme oxygenase inhibitor | |||
| 0.035 | 0.02 | 0.044 | Carboxypeptidase B inhibitor | 0.044 0.009 CID_10005178 | CID_10005178 | |
| 0.044 | 0.029 | 0.044 | Histamine H2 receptor agonist | |||
| 0.094 | 0.079 | 0.276 | Beta glucuronidase inhibitor | 0.276 0.007 CID_53831690 | CID_53831690 | |
| 0.057 | 0.042 | 0.057 | Botulinum neurotoxin type A inhibitor | |||
| 0.053 | 0.038 | 0.138 | Heparanase inhibitor | 0.091 0.004 CID_10005178 0.138 0.003 CID_53831690 | CID_53831690 | |
| 0.04 | 0.025 | 0.04 | Vascular adhesion protein 1 inhibitor | |||
| 0.023 | 0.009 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.02 | 0.006 | 0.02 | Thromboxane A2 agonist | |||
| 0.112 | 0.098 | 0.116 | Cytokine production inhibitor | 0.116 0.093 CID_10005178 | CID_10005178 | |
| 0.05 | 0.036 | 0.05 | Prolyl endopeptidase inhibitor | |||
| 0.059 | 0.045 | 0.059 | Cyclin B1 inhibitor | |||
| 0.018 | 0.005 | 0.018 | Glutamate (mGluR6) agonist | |||
| 0.022 | 0.009 | 0.022 | Progesterone receptor B antagonist | |||
| 0.054 | 0.041 | 0.054 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.035 | 0.023 | 0.035 | Calcitonin receptor agonist | |||
| 0.043 | 0.031 | 0.043 | Histamine H1 receptor agonist | |||
| 0.092 | 0.08 | 0.168 | Mediator release inhibitor | 0.168 0.022 CID_53831690 | CID_53831690 | |
| 0.074 | 0.062 | 0.36 | Antineoplastic antibiotic | 0.084 0.054 CID_10005178 0.36 0.007 CID_53831690 | CID_53831690 | |
| 0.064 | 0.053 | 0.13 | Carbonic anhydrase VA inhibitor | 0.13 0.015 CID_10005178 | CID_10005178 | |
| 0.027 | 0.016 | 0.027 | Prostaglandin H2 antagonist | |||
| 0.032 | 0.022 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | |||
| 0.199 | 0.189 | 0.199 | Calpain 2 inhibitor | |||
| 0.019 | 0.009 | 0.042 | Ileal bile acid transport inhibitor | 0.042 0.004 CID_53831690 | CID_53831690 | |
| 0.016 | 0.006 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.037 | 0.027 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.018 | 0.008 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 CID_10005178 | CID_10005178 | |
| 0.036 | 0.027 | 0.036 | 5-Alpha-reductase inhibitor | |||
| 0.027 | 0.018 | 0.027 | Retinoid X gamma receptor antagonist | |||
| 0.054 | 0.044 | 0.054 | Fatty acid synthase inhibitor | |||
| 0.044 | 0.034 | 0.139 | Phosphorylase inhibitor | 0.066 0.022 CID_10005178 0.139 0.008 CID_53831690 | CID_53831690 | |
| 0.045 | 0.035 | 0.049 | Antimetabolite | 0.049 0.032 CID_53831690 | CID_53831690 | |
| 0.1 | 0.091 | 0.1 | Acetylcholine muscarinic antagonist | |||
| 0.018 | 0.009 | 0.018 | Prostaglandin EP4 agonist | |||
| 0.077 | 0.069 | 0.077 | GABA A receptor agonist | |||
| 0.057 | 0.049 | 0.067 | NMDA 2C receptor antagonist | 0.067 0.036 CID_10005178 | CID_10005178 | |
| 0.103 | 0.094 | 0.103 | Nav1.3 sodium channel blocker | |||
| 0.059 | 0.051 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.029 | 0.021 | 0.029 | MAP3K8 inhibitor | |||
| 0.097 | 0.089 | 0.246 | DNA polymerase I inhibitor | 0.246 0.018 CID_53831690 | CID_53831690 | |
| 0.025 | 0.018 | 0.025 | Complement factor 1s inhibitor | 0.025 0.019 CID_10005178 | ||
| 0.058 | 0.051 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.023 | 0.016 | 0.023 | ICAM 1 antagonist | |||
| 0.144 | 0.137 | 0.144 | Anticonvulsant | |||
| 0.024 | 0.017 | 0.024 | 5 Hydroxytryptamine 4 agonist | |||
| 0.043 | 0.037 | 0.043 | Purinergic P2X4 antagonist | |||
| 0.033 | 0.026 | 0.033 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.046 | 0.04 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.048 | 0.042 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.025 | 0.019 | 0.027 | Thyroid hormone agonist | 0.027 0.017 CID_10005178 | CID_10005178 | |
| 0.032 | 0.026 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.046 | 0.04 | 0.046 | Cannabinoid CB2 receptor antagonist | |||
| 0.049 | 0.043 | 0.049 | Ribonucleotide reductase inhibitor | |||
| 0.018 | 0.012 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.013 | 0.008 | 0.013 | Carbonic anhydrase XI inhibitor | |||
| 0.036 | 0.031 | 0.036 | Urate transporter 1 inhibitor | |||
| 0.02 | 0.015 | 0.02 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.044 | 0.04 | 0.113 | Carbonic anhydrase XIV inhibitor | 0.113 0.008 CID_53831690 | CID_53831690 | |
| 0.058 | 0.053 | 0.058 | Neutrophil collagenase inhibitor | |||
| 0.059 | 0.055 | 0.178 | Carbonic anhydrase V inhibitor | 0.178 0.009 CID_10005178 | CID_10005178 | |
| 0.02 | 0.016 | 0.02 | Factor XIII inhibitor | |||
| 0.022 | 0.018 | 0.022 | CC chemokine 1 receptor antagonist | |||
| 0.036 | 0.033 | 0.036 | Retinoic acid alpha receptor agonist | |||
| 0.072 | 0.069 | 0.072 | Adrenaline agonist | |||
| 0.148 | 0.145 | 0.148 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.033 | 0.03 | 0.033 | Delayed rectifier potassium channel activator | |||
| 0.033 | 0.03 | 0.033 | Potassium channel KCNQ activator | |||
| 0.015 | 0.012 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.008 | 0.005 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.006 | 0.003 | 0.006 | Glucokinase regulatory protein inhibitor | |||
| 0.005 | 0.002 | 0.005 | Vitamin D-like | |||
| 0.038 | 0.036 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.011 | 0.009 | 0.011 | Immunosuppressant Cyclosporine-like | |||
| 0.014 | 0.012 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.018 | 0.016 | 0.018 | Caspase 8 inhibitor | |||
| 0.055 | 0.052 | 0.055 | Cyclin D1 inhibitor | |||
| 0.031 | 0.029 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.02 | 0.018 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.043 | 0.041 | 0.043 | Beta adrenoreceptor agonist | |||
| 0.202 | 0.2 | 0.202 | Toll-Like receptor agonist | |||
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | |||
| 0.016 | 0.014 | 0.016 | Aminopeptidase A inhibitor | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.108 | 0.106 | 0.108 | Toll-Like receptor antagonist | |||
| 0.058 | 0.057 | 0.058 | Matrix metalloproteinase inhibitor | |||
| 0.066 | 0.065 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.033 | 0.032 | 0.033 | Diamine oxidase inhibitor | |||
| 0.005 | 0.004 | 0.005 | Transcortin receptor antagonist | |||
| 0.009 | 0.009 | 0.013 | Purinergic P2Y2 agonist | 0.01 0.008 CID_10005178 0.013 0.004 CID_53831690 | CID_53831690 | |
| 0.044 | 0.05 | 0.058 | Cathepsin D inhibitor | 0.058 0.035 CID_10005178 | CID_10005178 | |
| 0.18 | 0.188 | 0.583 | Immunomodulator | 0.583 0.013 CID_53831690 | CID_53831690 | |
| 0.03 | 0.039 | 0.102 | Antibiotic Aminoglycoside-like | 0.102 0.003 CID_53831690 | CID_53831690 | |
| 0.184 | 0.195 | 0.36 | Caspase 3 stimulant | 0.36 0.056 CID_53831690 | CID_53831690 | |
| 0.049 | 0.061 | 0.115 | Adenine nucleotide translocase inhibitor | 0.115 0.004 CID_10005178 0.108 0.004 CID_53831690 | CID_10005178 | |
| 0.058 | 0.075 | 0.079 | Epoxide hydrolase inhibitor | 0.079 0.043 CID_10005178 | CID_10005178 | |
| 0.014 | 0.032 | 0.029 | Corticosteroid-like | 0.029 0.007 CID_53831690 | CID_53831690 | |
| 0.184 | 0.203 | 0.584 | Apoptosis antagonist | 0.584 0.011 CID_53831690 | CID_53831690 | |
| 0.035 | 0.058 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.031 CID_10005178 | CID_10005178 | |
| 0.021 | 0.045 | 0.057 | Toll-Like receptor 4 agonist | 0.057 0.003 CID_10005178 0.048 0.004 CID_53831690 | CID_10005178 | |
| 0.095 | 0.121 | 0.113 | Nav1.2 sodium channel blocker | 0.113 0.091 CID_10005178 | CID_10005178 | |
| 0.127 | 0.155 | 0.261 | P-glycoprotein inhibitor | 0.261 0.038 CID_53831690 | CID_53831690 | |
| 0.117 | 0.149 | 0.504 | Platelet adhesion inhibitor | 0.36 0.017 CID_10005178 0.504 0.005 CID_53831690 | CID_53831690 | |
| 0.135 | 0.168 | 0.622 | Free radical scavenger | 0.622 0.007 CID_53831690 | CID_53831690 | |
| 0.076 | 0.109 | 0.328 | Protein-tyrosine phosphatase 1B inhibitor | 0.328 0.009 CID_10005178 0.165 0.04 CID_53831690 | CID_10005178 | |
| 0.134 | 0.168 | 0.363 | Antiamyloidogenic | 0.363 0.036 CID_53831690 | CID_53831690 | |
| 0.013 | 0.047 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.016 CID_53831690 | CID_53831690 | |
| 0.015 | 0.049 | 0.085 | Protein 30S ribosomal subunit inhibitor | 0.085 0.004 CID_53831690 | CID_53831690 | |
| 0.073 | 0.11 | 0.121 | Protein kinase C zeta inhibitor | 0.121 0.032 CID_10005178 | CID_10005178 | |
| 0.003 | 0.044 | 0.022 | Antibiotic Macrolide-like | 0.022 0.006 CID_53831690 | CID_53831690 | |
| 0.024 | 0.068 | 0.97 | Cholecystokinin B agonist | 0.97 0.001 CID_10005178 | CID_10005178 | |
| 0.09 | 0.137 | 0.199 | Alkaline phosphatase inhibitor | 0.199 0.033 CID_10005178 0.108 0.103 CID_53831690 | CID_10005178 | |
| 0.126 | 0.175 | 0.382 | Platelet antagonist | 0.382 0.031 CID_53831690 | CID_53831690 | |
| 0.033 | 0.085 | 0.096 | Carbonic anhydrase inhibitor | 0.096 0.028 CID_10005178 | CID_10005178 | |
| 0.026 | 0.08 | 0.057 | Carbonic anhydrase I inhibitor | 0.057 0.037 CID_10005178 | CID_10005178 | |
| 0.008 | 0.063 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 CID_53831690 | CID_53831690 | |
| 0.055 | 0.112 | 0.112 | NMDA receptor antagonist | 0.112 0.04 CID_10005178 | CID_10005178 | |
| 0.057 | 0.114 | 0.135 | Chymotrypsin inhibitor | 0.135 0.021 CID_10005178 | CID_10005178 | |
| 0.007 | 0.069 | 0.167 | Estrone sulfatase inhibitor | 0.167 0.003 CID_10005178 | CID_10005178 | |
| 0.064 | 0.127 | 0.223 | Transcription factor NF kappa B stimulant | 0.223 0.007 CID_53831690 | CID_53831690 | |
| 0.01 | 0.077 | 0.612 | Cholecystokinin A antagonist | 0.612 0.002 CID_10005178 | CID_10005178 | |
| 0.062 | 0.13 | 0.166 | Uric acid excretion stimulant | 0.166 0.019 CID_53831690 | CID_53831690 | |
| 0.023 | 0.092 | 0.067 | Aldose reductase inhibitor | 0.067 0.029 CID_53831690 | CID_53831690 | |
| 0.012 | 0.081 | 0.558 | Cholecystokinin antagonist | 0.558 0.003 CID_10005178 | CID_10005178 | |
| 0.008 | 0.08 | 0.537 | Cholecystokinin B antagonist | 0.537 0.003 CID_10005178 | CID_10005178 | |
| 0.016 | 0.089 | 0.045 | Carbonic anhydrase XII inhibitor | 0.045 0.042 CID_53831690 | CID_53831690 | |
| 0.09 | 0.166 | 0.612 | Protein-tyrosine phosphatase inhibitor | 0.612 0.004 CID_10005178 0.159 0.07 CID_53831690 | CID_10005178 | |
| 0.014 | 0.093 | 0.042 | 1,3-Beta-glucan synthase inhibitor | 0.042 0.004 CID_10005178 0.031 0.012 CID_53831690 | CID_10005178 | |
| 0.054 | 0.133 | 0.324 | Topoisomerase I inhibitor | 0.324 0.009 CID_53831690 | CID_53831690 | |
| 0.028 | 0.11 | 0.291 | HIV-1 integrase (Strand Transfer) inhibitor | 0.291 0.005 CID_10005178 | CID_10005178 | |
| 0.014 | 0.097 | 0.152 | Estrogen agonist | 0.152 0.011 CID_10005178 0.042 0.041 CID_53831690 | CID_10005178 | |
| 0.006 | 0.089 | 0.042 | Estrogen receptor beta agonist | 0.042 0.021 CID_10005178 | CID_10005178 | |
| 0.035 | 0.118 | 0.269 | HIV-1 integrase (3'-Processing) inhibitor | 0.269 0.005 CID_10005178 | CID_10005178 | |
| 0.03 | 0.115 | 0.102 | NMDA 2 receptor antagonist | 0.102 0.031 CID_10005178 | CID_10005178 | |
| 0.164 | 0.254 | 0.392 | 15-Lipoxygenase inhibitor | 0.392 0.078 CID_10005178 | CID_10005178 | |
| 0.108 | 0.2 | 0.166 | CC chemokine 6 receptor antagonist | 0.166 0.009 CID_53831690 | CID_53831690 | |
| 0.01 | 0.105 | 0.023 | Motilin receptor agonist | 0.023 0.016 CID_53831690 | CID_53831690 | |
| 0.002 | 0.108 | 0.014 | Purinergic P2 agonist | 0.014 0.012 CID_53831690 | CID_53831690 | |
| 0.002 | 0.108 | 0.014 | Purinergic receptor agonist | 0.014 0.012 CID_53831690 | CID_53831690 | |
| 0.029 | 0.137 | 0.11 | Glucose-6-phosphate translocase inhibitor | 0.11 0.005 CID_53831690 | CID_53831690 | |
| 0.011 | 0.125 | 0.022 | Follicle-stimulating hormone antagonist | 0.022 0.008 CID_10005178 | CID_10005178 | |
| 0.006 | 0.122 | 0.87 | Cholecystokinin agonist | 0.87 0.001 CID_10005178 | CID_10005178 | |
| 0.023 | 0.14 | 0.136 | Elastase inhibitor | 0.136 0.005 CID_10005178 | CID_10005178 | |
| 0.063 | 0.18 | 0.208 | Toll-Like receptor 4 antagonist | 0.208 0.005 CID_53831690 | CID_53831690 | |
| 0.035 | 0.156 | 0.209 | Topoisomerase II alpha inhibitor | 0.209 0.014 CID_53831690 | CID_53831690 | |
| 0.048 | 0.178 | 0.292 | Topoisomerase II inhibitor | 0.292 0.019 CID_53831690 | CID_53831690 | |
| 0.026 | 0.17 | 0.241 | Factor IXa inhibitor | 0.241 0.003 CID_10005178 0.127 0.005 CID_53831690 | CID_10005178 | |
| 0.01 | 0.161 | 0.074 | Factor Xa inhibitor | 0.074 0.019 CID_10005178 | CID_10005178 | |
| 0.021 | 0.174 | 0.485 | Selectin antagonist | 0.393 0.003 CID_10005178 0.485 0.003 CID_53831690 | CID_53831690 | |
| 0.096 | 0.255 | 0.43 | Vasodilator | 0.43 0.019 CID_53831690 | CID_53831690 | |
| 0.006 | 0.168 | 0.021 | Adenosine A1 receptor agonist | 0.021 0.02 CID_53831690 | CID_53831690 | |
| 0.01 | 0.18 | 0.212 | NMDA 2D receptor antagonist | 0.212 0.003 CID_10005178 | CID_10005178 | |
| 0.005 | 0.176 | 0.852 | Cholecystokinin A agonist | 0.852 0.001 CID_10005178 | CID_10005178 | |
| 0.062 | 0.235 | 0.495 | Cell adhesion inhibitor | 0.495 0.004 CID_53831690 | CID_53831690 | |
| 0.006 | 0.187 | 0.026 | Purinergic P2X agonist | 0.026 0.02 CID_10005178 | CID_10005178 | |
| 0.016 | 0.198 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.021 CID_53831690 | CID_53831690 | |
| 0.115 | 0.307 | 0.364 | Alpha-glucosidase inhibitor | 0.364 0.129 CID_53831690 | CID_53831690 | |
| 0.019 | 0.225 | 0.048 | Protein kinase C eta inhibitor | 0.048 0.047 CID_53831690 | CID_53831690 | |
| 0.169 | 0.383 | 0.891 | Antiinflammatory | 0.532 0.075 CID_10005178 0.891 0.005 CID_53831690 | CID_53831690 | |
| 0.026 | 0.243 | 0.668 | CDC25A inhibitor | 0.668 0.002 CID_10005178 | CID_10005178 | |
| 0.038 | 0.267 | 0.404 | Cell adhesion molecule inhibitor | 0.092 0.04 CID_10005178 0.404 0.004 CID_53831690 | CID_53831690 | |
| 0.031 | 0.287 | 0.116 | ATPase (Vacuolar H+) inhibitor | 0.116 0.022 CID_53831690 | CID_53831690 | |
| 0.017 | 0.316 | 0.074 | Nitric oxide donor | 0.074 0.028 CID_53831690 | CID_53831690 | |
| 0.015 | 0.328 | 0.085 | Lipase inhibitor | 0.085 0.038 CID_53831690 | CID_53831690 | |
| 0.114 | 0.436 | 0.765 | Apoptosis agonist | 0.765 0.021 CID_53831690 | CID_53831690 | |
| 0.036 | 0.36 | 0.171 | Nav1.4 sodium channel blocker | 0.171 0.026 CID_10005178 | CID_10005178 | |
| 0.052 | 0.404 | 0.538 | Tumour necrosis factor alpha release inhibitor | 0.538 0.011 CID_53831690 | CID_53831690 | |
| 0.035 | 0.398 | 0.75 | Dual specificity phosphatase 3 inhibitor | 0.75 0.003 CID_10005178 | CID_10005178 | |
| 0.02 | 0.395 | 0.083 | Histone deacetylase SIRT1 stimulant | 0.083 0.041 CID_53831690 | CID_53831690 | |
| 0.02 | 0.395 | 0.083 | Histone deacetylase stimulant | 0.083 0.041 CID_53831690 | CID_53831690 | |
| 0.041 | 0.424 | 0.218 | Beta lactamase inhibitor | 0.218 0.174 CID_10005178 | CID_10005178 | |
| 0.029 | 0.46 | 0.753 | Dual specificity phosphatase inhibitor | 0.753 0.003 CID_10005178 | CID_10005178 | |
| 0.018 | 0.476 | 0.181 | Cyclooxygenase 1 inhibitor | 0.181 0.043 CID_53831690 | CID_53831690 | |
| 0.024 | 0.482 | 0.098 | Thioredoxin inhibitor | 0.098 0.05 CID_53831690 | CID_53831690 | |
| 0.036 | 0.518 | 0.158 | Interleukin 6 antagonist | 0.158 0.078 CID_53831690 | CID_53831690 | |
| 0.01 | 0.497 | 0.094 | Purinergic P2Y2 antagonist | 0.094 0.004 CID_10005178 | CID_10005178 | |
| 0.017 | 0.514 | 0.064 | Trypsin inhibitor | 0.064 0.039 CID_10005178 | CID_10005178 | |
| 0.018 | 0.545 | 0.128 | Cyclooxygenase inhibitor | 0.128 0.09 CID_53831690 | CID_53831690 | |
| 0.014 | 0.548 | 0.117 | Cyclooxygenase 2 inhibitor | 0.117 0.083 CID_53831690 | CID_53831690 | |
| 0.039 | 0.578 | 0.362 | NOS3 expression enhancer | 0.362 0.01 CID_53831690 | CID_53831690 | |
| 0.013 | 0.64 | 0.86 | Anticoagulant | 0.86 0.004 CID_10005178 0.281 0.032 CID_53831690 | CID_10005178 | |
| 0.011 | 0.649 | 0.119 | DNA intercalator | 0.119 0.058 CID_53831690 | CID_53831690 | |
| 0.003 | 0.725 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_53831690 | CID_53831690 | |
| 0.005 | 0.779 | 0.133 | Thrombin inhibitor | 0.133 0.014 CID_10005178 | CID_10005178 | |
| 0.011 | 0.829 | 0.827 | Angiogenesis inhibitor | 0.827 0.005 CID_10005178 | CID_10005178 | |
| 0.007 | 0.869 | 0.221 | Multidrug resistance-associated protein 1 inhibitor | 0.221 0.007 CID_10005178 0.13 0.038 CID_53831690 | CID_10005178 | |
| 0.004 | 0.877 | 0.485 | NMDA 2B receptor antagonist | 0.485 0.003 CID_10005178 | CID_10005178 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |